Menu
GWAS Study

Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.

Treviño LR, Shimasaki N, Yang W et al.

19901119 PubMed ID
GWAS Study Type
640 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TL
Treviño LR
SN
Shimasaki N
YW
Yang W
PJ
Panetta JC
CC
Cheng C
PD
Pei D
CD
Chan D
SA
Sparreboom A
GK
Giacomini KM
PC
Pui CH
EW
Evans WE
RM
Relling MV
Chapter II

Abstract

Summary of the research findings

Purpose: Methotrexate plasma concentration is related to its clinical effects. Our aim was to identify the genetic basis of interindividual variability in methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia (ALL).

315 European ancestry cases, 73 African American cases, 5 Asian ancestry cases, 247 cases

Chapter III

Study Statistics

Key metrics and study information

640
Total Participants
GWAS
Study Type
No
Replicated
Asian unspecified, Other, European, African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.